tldrdailynews.com logo

"FDA Approves Revolutionary Cell Therapy for Aggressive Melanoma Treatment"

1 min read
Source: NPR
"FDA Approves Revolutionary Cell Therapy for Aggressive Melanoma Treatment"
Photo: NPR
TL;DR

The FDA has approved Amtagvi, a novel cell therapy developed by Iovance Biotherapeutics, to treat aggressive forms of melanoma, making it the first cell therapy for solid tumors to receive FDA approval. Amtagvi works by using immune system cells from a patient's tumor to fight advanced melanoma. This treatment represents a significant advancement for patients with limited options, and while it has been fast-tracked for approval, additional trials are being conducted to confirm its efficacy. Melanoma, although accounting for only 1% of skin cancer cases, is linked to a significant number of cancer-related deaths, and Amtagvi offers a promising new option for those affected by this aggressive form of cancer.

Topics:businesshealth#amtagvi#cell-therapy#fda#health#iovance-biotherapeutics#melanoma
Share this article
  1. FDA approves first cell therapy to treat aggressive forms of melanoma  NPR
  2. FDA approves Iovance's Amtagvi as first cell therapy for a solid tumor  FiercePharma
  3. FDA approves groundbreaking treatment for advanced melanoma  NBC News
  4. FDA approves new therapy for hard-to-treat metastatic melanoma  CNN
  5. Camden woman cancer-free after being 1st patient for new FDA approved cancer treatment  CBS News

Want the full story? Read the original reporting

Read on NPR